Once-daily treatment for canine atopic dermatitis
Delivers 6-in-1 parasite protection for cats
Valuable discounts, expert information, and tips
See how injectable medications offer value beyond the prescription
The first and only FDA-Approved veterinary antiemetic
The first long-lasting monoclonal antibody therapy for canine atopic dermatitis
Vaccination for the prevention of respiratory disease caused by BRSV
The beef industry’s No. 1 branded preconditioning program
Exclusive pricing program for Cattle producers
Outstanding protection against costly respiratory and reproductive diseases
Treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites
Innovative food safety products that help deliver a farm-to-fork solution for beef
The most comprehensive guarantee available
First and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses
Annual vaccination with CORE EQ INNOVATOR helps provide the protection your horse needs
Treats and controls encysted small strongyles, bots and roundworms. QUEST PLUS contains an additional active ingredient for efficacy against tapeworms
Patented and scientific method of determining fair service pricing to improve your clinic's profitability
Connect directly to valuable dairy management resources and experts
The most "veterinarian recommended" and "producer used" prostaglandin in the market
Delivers the peace of mind and profitability that come with no milk discard
Effective and convenient treatment for acute metritis in cattle
Working together to improve reproduction
One injection treats and controls swine respiratory disease for 7 days
Protect sows and gilts from costly breeding herd diseases — parvovirus, leptospirosis and erysipelas
The industry standard for in ovo technology.
Full automation solutions for hatchery automation
Prevention and control of necrotic enteritis, increased rate of weight gain and improved feed efficiency in poultry
for the prevention of coccidiosis in poultry
modified-live vaccine that helps poultry companies reduce their overall Salmonella load
Blood glucose monitoring system
Smart new diagnostics platform that can reinvent your in-house diagnostic routines
Detect Johne’s Disease with confidence in cattle and goat herds
Simple and effective detection of a deadly Feline Virus
Accurate, affordable and easy to use
Order Beef Genetics products online
Order Dairy Genetics products online
Delivers reliable predictions of genetic merit based on test results of core traits
Represents the latest advancement in Angus genotyping technology.
Register today to learn more
Become a more effective leader
Looking for a tailored experience?
Earn continuing education credits and stay current on industry developments with Zoetis’ convenient, on-demand learning solutions.
Veterinarians, Veterinarian Techs, Business Owners, and Farm Hands
Launch your veterinary career
Veterinarian Students and Recent Graduates
Animal health expertise and results-focused resources for high-performing teams and leaders.
Veterinarians, Dairy producers, Beef producers, Equine Specialists, Pork producers, Poultry producers, Managers, Business Owners and Staff
Home / NEWS & MEDIA / New Study Shows FLUVAC INNOVATOR® Is Cross-reactive Against Three Recent OIE Equine Influenza Isolates
FLUVAC INNOVATOR is most tested and trusted EIV vaccine on the market1-7
FLORHAM PARK, N.J., Aug. 7, 2015 — Amid equine influenza virus (EIV) season, a new Zoetis study showed FLUVAC INNOVATOR® to be cross-reactive against three emerging World Organization for Animal Health (OIE) equine influenza isolates.1
The study demonstrated sera from horses vaccinated with EIV vaccine FLUVAC INNOVATOR EHV 4/1 or FLUVAC INNOVATOR 5 were cross-reactive against:•Ayrshire 2013 (AY/13), European clade 2 isolate1 •Kentucky 2014 (KY/14), North American clade 1 isolate1•Texas 2012 (TX/12), North American clade 1 isolate1
The vaccinates demonstrated at least 97.4% cross-reactivity to these three recent EIV isolates. These high rates of seroconversion demonstrated that FLUVAC INNOVATOR continues to be immunologically relevant against newly emerging North American clade 1 and European clade 2 EIV strains.
“These are the most recent OIE isolates that we have on file at the OIE reference lab at the University of Kentucky,” said Robert Holland, DVM, PhD, director of Zoetis Outcomes Research. “In result, there were good cross-reactive antibodies when vaccinated with Kentucky/97 FLUVAC INNOVATOR against those strains.”
Zoetis regularly tests FLUVAC INNOVATOR to ensure that it is immunogenic against emerging EIV isolates. A total of six studies have demonstrated that Kentucky/97 is effective against nine emerging strains.1-6 Four studies were challenge-of-immunity tests, the gold standard for determining vaccine efficacy.2-5 In each challenge study, the Kentucky/97 vaccine virus was shown to help protect against the EIV challenge strain.
Equine influenza is one of the most common respiratory diseases in horses, spreading by aerosol transmission (coughing or sneezing) from horse to horse in distances as far as 50 yards.8
“All horses are considered at risk for influenza, and when they get influenza, they can be down and out of work for up to three weeks because the virus can cause such damage,” said Holland. “I recommend FLUVAC INNOVATOR EHV-4/1 vaccination booster for all my horses in the fall.”
Veterinarians and horse owners who choose FLUVAC INNOVATOR vaccines can have confidence that their product is the most tested and trusted EIV vaccine on the market.1-7
Zoetis INNOVATOR vaccines are supported by the Zoetis Equine Immunization Support Guarantee, which means if a horse is properly vaccinated by a veterinarian with Zoetis antigens and contracts the corresponding equine disease, Zoetis will provide up to $5,000 in diagnostic and treatment costs. The Equine Immunization Support Guarantee covers the following: •Equine influenza•Equine herpesvirus Types 1 and 4, respiratory (new)•West Nile•Eastern, Western and Venezuelan encephalitis•Tetanus
“Properly administered vaccines help reduce the risk of infection, so we encourage horse owners to work with their veterinarian to formulate a complete vaccination program addressing the core and risk diseases,” said Zoetis Technical Services Veterinarian Kevin Hankins, DVM, MBA. “The Equine Immunization Support Guarantee program is an opportunity for horse owners to discuss their concerns with their veterinarian and ultimately help provide the best possible health care to their horses.”
Click here to view a video explaining how vaccines are tested and evaluated, including highlights of the results from the recent Zoetis study. For more information, visit FluvacInnovator.com.
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2014, the company generated annual revenue of $4.8 billion. With approximately 10,000 employees worldwide at the beginning of 2015, Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in 120 countries. For more information, visit www.zoetisUS.com.
For Further Information,Contact:
Suzanne DorisBader Rutter email@example.com
1 Data on file, Study Report No. 15EQRGBIO-02, Zoetis Inc.2 Data on file, Study Report No. 671-02-001R, Zoetis Inc.3 Data on file, Study Report No. 671-08-004.R, Zoetis Inc.4 Data on file, Study Report No. 766-09-002.R, Zoetis Inc.5 Data on file, Study Report No. 10OREQBIO-01, Zoetis Inc.6 Data on file, Study Report No. 14OREQBIO-1, Zoetis Inc.7 West Nile-Innovator and Fluvac Innovator MDI Sales Data as of 12/31/14. Zoetis. Dec. 2014.8 American Association of Equine Practitioners. Suspected Case of Contagious Infectious Respiratory Disease. Available at: http://aaep.org/custdocs/Respiratory%20Guidelines.pdf. Accessed July 27, 2015.
Mon–Fri, 8am–8pm ET
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
This site is intended for U.S. Animal Healthcare Professionals.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2017 Zoetis Services LLC. All rights reserved.